Michael Koby is a Partner at 1315 Capital and has spent his entire career as a health care investor and operator, including experience with more than 20 growth equity investments. Most recently Michael spent four years as Managing Director at Palm Ventures, a private-equity focused family office. At Palm, he led all healthcare investing, including the purchase of Nutrition 21 Inc., forming the basis for JDS THERAPEUTICS.
Before Palm Ventures, Michael spent eight years as an investor at Galen Partners, a healthcare growth equity investment firm, and three years on the operating side as a director of financial planning and business development at Novoste Corporation. Michael started his career as a healthcare investment banking analyst at Dillon, Read & Co.
Michael earned a B.S. in Economics from Cornell University and an M.B.A. in Healthcare Management from The Wharton School.